Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients

First Page		Document Content
Date: 2014-02-21 12:10:36 Stem cells Transplantation medicine Graft-versus-host disease Hematopoietic stem cell transplantation Cell therapy Center for International Blood and Marrow Transplant Research Donor lymphocyte infusion Stem cell treatments Rituximab Medicine Biology Health		Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients Add to Reading List Source URL: mesoblast.com Download Document from Source Website File Size: 260,42 KB Share Document on Facebook

	Guideline for the Management of Fever and Neutropenia in Children with Cancer and/or Undergoing Hematopoietic Stem-Cell Transplantation COG Supportive Care Endorsed Guidelines Click here to see all the COG Supportive Car DocID: 1tWUj - View Document
	Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer DocID: 1riiF - View Document
	UMBILICAL CORD BLOOD BANKING A guide for parents This guide has been elaborated by the Council of Europe European DocID: 1rf0W - View Document
	Lifebank_Logo_withTag-centered DocID: 1rakV - View Document
	ART I CL E Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment Isabelle J. Fugier-Vivier,1,2 Francine Rezzoug,1 Yiming Huang,1 DocID: 1r5hr - View Document